ETF MANAGERS GROUP, LLC - GALMED PHARMACEUTICALS LTD ownership

GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 32 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ETF MANAGERS GROUP, LLC ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2020$254,000
-21.6%
72,640
+8.4%
0.01%
-27.3%
Q2 2020$324,000
+126.6%
66,991
+61.2%
0.01%
+57.1%
Q1 2020$143,000
-33.8%
41,548
+9.8%
0.01%
-12.5%
Q4 2019$216,000
-5.3%
37,856
-19.0%
0.01%0.0%
Q3 2019$228,000
-19.1%
46,734
+3.3%
0.01%
-11.1%
Q2 2019$282,000
+2.9%
45,222
+34.7%
0.01%
-30.8%
Q1 2019$274,000
+15.6%
33,573
-3.1%
0.01%
+18.2%
Q4 2018$237,000
-25.0%
34,656
+48.9%
0.01%
-8.3%
Q3 2018$316,000
+315.8%
23,274
+54.5%
0.01%
+140.0%
Q1 2018$76,000
-36.1%
15,068
+19.1%
0.01%
-44.4%
Q4 2017$119,00012,6550.01%
Other shareholders

There were no reported owners of GALMED PHARMACEUTICALS LTD in Q1 2020.

NameSharesValueWeighting ↓
View complete list of GALMED PHARMACEUTICALS LTD shareholders